Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system. - Reus P; Guthmann H; Uhlig N; Agbaria M; Issmail L; Eberlein V; Nordling-David MM; Jbara-Agbaria D; Ciesek S; Bojkova D; Cinatl J; Burger-Kentischer A; et al. (Journal of controlled release : official journal of the Controlled Release Society, 2023)